Cel Sci CVM
NYSE CVM
$1.32 -0.08 (-5.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Cel Sci (CVM) Price to Sales (2015 - 2023)

Updated

Cel Sci's Price to Sales was 80.40 in fiscal Q3 2017 (quarter ended Jun 30, 2017).

Analysis

Cel Sci (CVM) Price to Sales (2015 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cel Sci 58.11 Mn 32.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 15,888.58
Mar 31, 2020 210,159.60
Jun 30, 2015 46,614.97
Mar 31, 2015 29,258.36
API Access

Cel Sci Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=CVM&period=max&api_key=YOUR_API_KEY